Giorgio Giacomo Galli

Giorgio Giacomo Galli

Auto-generated profile, based on publicly available information

Giorgio Giacomo Galli

Novartis Biomedical Research, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Cell
Verified
Journal Article
Closed access
DYDean Yimlamai
Dean Yimlamai
CCConstantina Christodoulou
Constantina Christodoulou
GGGiorgio G. Galli
Giorgio G. Galli
KYKilangsungla Yanger
Kilangsungla Yanger
BPBrian Pepe-Mooney
Brian Pepe-Mooney
FCFernando D. Camargo
Fernando D. Camargo

1 July 2017 in Cell
Verified
Journal Article
Closed access
EME. Robert McDonald
E. Robert McDonald
AWAntoine de Weck
Antoine de Weck
MSMichael R. Schlabach
Michael R. Schlabach
EBEric Billy
Eric Billy
KMKonstantinos J. Mavrakis
Konstantinos J. Mavrakis
WSWilliam R. Sellers
William R. Sellers

8 May 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
HLHaoxin Li
Haoxin Li
SNShaoyang Ning
Shaoyang Ning
MGMahmoud Ghandi
Mahmoud Ghandi
GKGregory V. Kryukov
Gregory V. Kryukov
SGShuba Gopal
Shuba Gopal
WSWilliam R. Sellers
William R. Sellers

1 October 2015 in Molecular Cell
Verified
Journal Article
Closed access
GGGiorgio G. Galli
Giorgio G. Galli
MCMatteo Carrara
Matteo Carrara
WYWei-Chien Yuan
Wei-Chien Yuan
CVChristian Valdes-Quezada
Christian Valdes-Quezada
BGBasanta Gurung
Basanta Gurung
FCFernando D. Camargo
Fernando D. Camargo

18 July 2016 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
ACAndrew G. Cox
Andrew G. Cox
KLKatie N. Lee
Katie N. Lee
KBKristin K. Brown
Kristin K. Brown
KEKimberley J. Evason
Kimberley J. Evason
SBSebastian Beltz
Sebastian Beltz
WGWolfram Goessling
Wolfram Goessling
The Hippo pathway is an important regulator of organ size and tumorigenesis. It is unclear, however, how Hippo signalling provides the cellular building blocks required for rapid growth. Here, we demonstrate that transgenic zebrafish expressing an activated form of the Hippo pathway effector Yap1 (also known as YAP) develop enlarged livers and are prone to liver tumour formation. Transcriptomic and metabolomic profiling identify that Yap1 reprograms glutamine metabolism. Yap1 directly enhances glutamine synthetase (glul) expression and activity, elevating steady-state levels of glutamine and enhancing the relative isotopic enrichment of nitrogen during de novo purine and pyrimidine biosynthesis. Genetic or pharmacological inhibition of GLUL diminishes the isotopic enrichment of nitrogen into nucleotides, suppressing hepatomegaly and the growth of liver cancer cells. Consequently, Yap-driven liver growth is susceptible to nucleotide inhibition. Together, our findings demonstrate that Yap1 integrates the anabolic demands of tissue growth during development and tumorigenesis by reprogramming nitrogen metabolism to stimulate nucleotide biosynthesis.

8 February 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MIMario Iurlaro
Mario Iurlaro
MSMichael B. Stadler
Michael B. Stadler
FMFrancesca Masoni
Francesca Masoni
ZJZainab Jagani
Zainab Jagani
GGGiorgio G. Galli
Giorgio G. Galli
DSDirk Schübeler
Dirk Schübeler